Table 1.
Selected lncRNAs involved in stroke pathogenesis.
| LncRNA | Target (s) | Effect (s) | Study models | Ref |
|---|---|---|---|---|
| N1LR | Maybe inactivates p53 | Inhibits neural death and apoptosis probably via reducing p53 phosphorylation | In vitro: N2a cells In vivo: SD rats, mice | [76] |
| MALAT1 | E-selectin and Bim | Inhibits inflammation and endothelial cell death and defends cerebral parenchyma and microvasculature from brain ischemic injury. | In vitro: BMECs In vivo: C57BL/6 mice | [83] |
| H19 | DUSP5-ERK1/2 | Silenced autophagy which activated by OGD/R via DUSP5-ERK1/2 axis. | In vitro: SH-SY5Y cells In vivo: SD rats | [84] |
| TUG1 | miR-9/Bcl2l11 | Inhibits miR-9 and weakened suppression of bcl2l11 expression and so, leads a neurotoxicity after stroke. | In vitro: SH-SY5Y cells In vivo: SD rats | [85] |
| C2dat1 | CaMKIIδ | Increases the CaMKIIδ expression and activates NF-κB signal impacting neuronal survival after ischemic stroke. | n vitro: N2a cells In vivo: C57BL/6 mice | [86] |
| ANRIL | VEGF/NF-κB | Increases VEGF expression and activates angiogenesis via activation of NF-κB pathway | In vivo: male Wistar rats | [87] |